The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
![USA, Brazil flags](https://www.greenhill.com/sites/default/files/us_brazil_flag.png)
NII Holdings’ operations in Brazil (“Nextel Brazil”)
![Mexico Mexico flag](https://www.greenhill.com/sites/default/files/mexico.gif)
Advised NII Holdings, a provider of mobile communications services in Brazil, on the sale of its 70% interest in its operations in Brazil (“Nextel Brazil”) to América Móvil
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Pfizer Inc. Consumer Health Business
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advised GlaxoSmithKline plc ("GSK"), the UK listed international pharmaceutical and consumer healthcare company, on the combination of GSK's and Pfizer's Consumer Health businesses to create a world-leading Joint Venture
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Starpharma Holdings Limited, patented VivaGel BV® product
![Italy, USA flags](https://www.greenhill.com/sites/default/files/italian-us-flag.png)
Advised Starpharma Holdings Limited on a US licensing agreement of its patented VivaGel BV® product with ITF Pharma, a US subsidiary of Italfarmaco S.p.A., a privately held European specialty pharmaceutical company
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Assets owned by GlaxoSmithKline plc
![](https://www.greenhill.com/sites/default/files/uk_india_flags.png)
Advised GlaxoSmithKline plc, the UK listed international pharmaceutical and consumer healthcare company, on the divestment of Horlicks and other consumer healthcare nutrition brands to Unilever plc, and on the merger of GSK Consumer Healthcare Limited with Hindustan Unilever Limited
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Aisthesis
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Aisthesis, a portfolio company of Triton Pacific Capital Partners, on its sale to NAPA, a portfolio company of American Securities
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Sky plc
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Acted on behalf of a group of independent shareholders of Sky plc, representing their interests at the Hearings Committee of the UK Takeover Panel and at the Takeover Appeals Board in the context of the Panel’s determination of a Chain Principle Offer price payable by Disney for Sky
![Canada Canada flag](https://www.greenhill.com/sites/default/files/canada.gif)
Common shares and common share purchase warrants in Canopy Growth
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Canopy Growth on a C$5bn investment by Constellation Brands. As consideration for the investment, Constellation received newly issued Canopy common shares and common share purchase warrants
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Best Lawyers, LLC
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Best Lawyers, the oldest and most respected peer review publication and digital media company in the global legal community, on its sale to Levine Leichtman Capital Partners
![Canada Canada flag](https://www.greenhill.com/sites/default/files/canada.gif)
Concordia International Corp.
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised an Ad Hoc Group of Cross-over Debtholders on Concordia International’s cross-border Canadian restructuring and recapitalization, including a US$586.5mm common equity private placement, the equitization of ~US$1.7bn of unsecured debt and the partial paydown and exchange of ~US$2.2bn of secured debt
![Spain, France flags](https://www.greenhill.com/sites/default/files/spain-france-flags.png)
IslaLink
![Canada Canada flag](https://www.greenhill.com/sites/default/files/canada.gif)
Advised EQT, a leading alternative investments firm with more than EUR 37 billion of AUM on the sale of its portfolio company IslaLink, a leading neutral and independent submarine fiber infrastructure operator in the Balearic Islands
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Cityfibre Infrastructure Holdings plc
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Antin Infrastructure Partners and West Street Infrastructure Partners, part of Goldman Sachs’ Merchant Banking division, in connection with the take private of CityFibre Infrastructure Holdings plc, a leading independent provider of wholesale fibre network infrastructure
![Switzerland Switzerland flag](https://www.greenhill.com/sites/default/files/switzerland.gif)
Novartis AG’s 36.5% stake in Consumer Health Joint Venture
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advised and acted as sponsor to GlaxoSmithKline plc, the UK’s leading pharmaceutical company, on the buyout of Novartis’ 36.5% stake in their Consumer Health Joint Venture
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Midwest Television, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised TEGNA, Inc., a major broadcasting and digital marketing services company, on the acquisition of Midwest Television, Inc.
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
MorphoSys AG
![China China flag](https://www.greenhill.com/sites/default/files/china.gif)
Advised MorphoSys AG, a German biopharmaceutical company, on a regional licensing agreement covering Greater China and comprising its investigational anti-CD38 antibody MOR202 targeting multiple myeloma, with I-Mab
![South Africa/Switzerland South Africa, Switzerland flags](https://www.greenhill.com/sites/default/files/s-africa_switz_91006.gif)
Hirslanden Private Hospital Group
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised Hirslanden Private Hospital Group, Switzerland's largest private hospital group and a wholly-owned subsidiary of Mediclinic International Plc, on the refinancing of its CHF 2.0 billion senior secured bank debt
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
CareerBuilder, LLC
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised TEGNA, Inc., a leading broadcasting company, on the sale of its 53% ownership stake in CareerBuilder, LLC for $250 million of cash proceeds and 12.5% ongoing ownership
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
F+W Media
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised F+W Media, a content and e-commerce company focused on a variety of special interest categories, on the out-of-court restructuring of its c.$100 million term loan and a $15 million new money investment from existing lenders
![Saudi Arabia Saudi Arabia Flag](https://www.greenhill.com/sites/default/files/saudiarabia.gif)
Equity stake in Bupa Arabia
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advised Bupa, a leading international healthcare group, on the increase of its stake in Bupa Arabia, one of the largest health insurance providers in the Kingdom of Saudi Arabia
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Ad Hoc Group of Senior Secured Noteholders
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised the Ad Hoc Group of Senior Secured Noteholders in connection with the restructuring of Goodman Networks.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Derma Sciences, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Derma Sciences, Inc., a tissue regeneration company focused on advanced wound and burn care, on its sale to Integra LifeSciences Holdings Corporation, a global leader in medical technology
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Palatin Technologies, Inc. lead product candidate, Rekynda
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Palatin Technologies, Inc. on the exclusive licensing of North American rights to develop and commercialize RekyndaTM (bremelanotide), an investigational product designed for on-demand treatment for hypoactive sexual desire disorder in pre-menopausal women, to AMAG Pharmaceuticals, Inc.
![U.K., German flags](https://www.greenhill.com/sites/default/files/uk_germany.gif)
Host Europe Group
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised GoDaddy, the largest domain name registrar worldwide and a leading web hosting provider, on its acquisition of Host Europe Group, the largest privately owned web services provider in Europe
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Adams Media
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised F+W Media, a content and e-commerce company, on the divestment its consumer book publishing business, Adams Media, to Simon & Schuster, a division of CBS Corporation
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
IAC/InterActiveCorp
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised the Special Committee of the Board of Directors of IAC/InterActiveCorp, a leading media and internet company, on the potential creation of a new class of non-voting common stock
![USA/Canada U.S.A., Canada flags](https://www.greenhill.com/sites/default/files/usa_canada.gif)
Concordia International Corp
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised the Special Committee of the Board of Directors of Concordia International, a diverse, international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs, on its strategic review process